Pharmaceutical Manufacturing – Zinc Oxide Ointment

The contract requires the manufacture and supply of ten units of 20% zinc oxide ointment packaged in one-ounce collapsible tubes, fully compliant with U.S. Pharmacopeia, Food and Drug Administration, and military packaging specifications. The product must meet rigorous quality and safety standards to ensure suitability for use in military medical environments, with all packaging and labeling adhering to federal and defense requirements. The ointment is intended for distribution to a U.S. Department of Defense facility located at APO 96543-4010, indicating the end-use is tied to overseas or military operational needs. This is a subcontract solicitation issued under NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing, with a response deadline of May 18, 2026, and the opportunity was posted on May 11, 2026. The contracting activity is managed by the Medical Supply Chain Pharm FSA under the Department of Defense, suggesting the order is part of a broader medical supply chain initiative. While no set-aside classification is specified, the requirement is strictly defined and targets suppliers with the capability to produce pharmaceutical-grade ointments under federal regulatory and military compliance frameworks.